The partner
behind the strategy.
Kjell de Orr is the Founder and Managing Partner of 7BridgesGroup, a growth and go-to-market consultancy based in the USA and Stockholm, specialising in cross-border expansion across the USA, LATAM, Scandinavia and Europe.
In a career of 25+ years spanning leadership roles at global digital marketing, data analytics and business transformation firms across four continents, Kjell has driven vision, strategy and execution for enterprise technology innovation initiatives that have consistently delivered company growth, operational excellence and customer success. He has managed P&Ls of up to $155M, led international teams of 1,500+, and guided companies through exits and acquisitions ranging from $2M to $525M in value.
Prior to founding 7BridgesGroup, Kjell served as Managing Partner at Newlink Group, where he built and led the Insights, Strategy, Digital, Data, AI, Analytics and Innovation practice across seven countries. As CEO of IBOPE Inteligência USA (Kantar), he launched the brand in the US, managed 250 US-based employees, directed operations in Mexico and Puerto Rico, and launched IBOPE's online research business in Brazil. Earlier, as Global SVP and MD of the Global Technology Practice at Research International / Kantar / WPP, based in London, he built a Top 10 UK agency with $30M revenue and 60+ consultants, earning a UK Board Membership — bringing in and growing the Vodafone account to $250M in annual WPP group revenue. As SVP Global Key Accounts, he led the Ericsson, Sony Ericsson, Vodafone, Diageo and Nestlé accounts globally.
Kjell also served as Joint Interim CEO at IPSOS Interactive Services (London & Bucharest), driving corporate revenue to more than double while overseeing a 500-member tech team, as Chairman & CEO of GfK Martin Hamblin UK & USA, where he turned around a $40M pharma research business and led the $525M acquisition of NOP World to build a $155M+ combined consulting firm, and as Managing Partner at Box Innovation & Transformation at LSE, leading strategy and innovation programmes for FTSE100 and Fortune 500 corporations focused on disruptive technologies. He served as Exec Director & Head of Strategy, Innovation & Partnerships at MIT Global CoCreationLab — a collaboration between MIT, MIT IMES and Miami-Dade County — co-leading venture build-out and market launch for AI Health & Wellness start-ups. He is a sought-after advisor and board member across multiple high-growth ventures. Amongst others, he currently serves as Board Advisor at Poietis Biosystems (Bordeaux), developer of the world’s first clinical-grade robotic laser BIOprinter at the frontier of regenerative medicine.
Kjell holds dual MBAs in Finance and Marketing from Örebro University, Sweden, and a BA from Uppsala University, Sweden. He works directly with founders, CEOs and corporate leadership teams across DeepTech, HealthTech & MedTech, BioTech & Longevity, Cybersecurity, Energy & Sustainability, Automation & Robotics and FoodTech & Nutrition — guiding companies through investor readiness, regulatory navigation, market entry and commercial scale-up across all four markets.
